Sublethal concentrations of diverse gold compounds inhibit mammalian cytosolic thioredoxin reductase (TrxR1)

Toxicology in Vitro : an International Journal Published in Association with BIBRA
Yo OmataJohn C Wataha

Abstract

Thioredoxin reductase (TrxR) reduces thioredoxin (Trx), thereby contributing to cellular redox balance, facilitating the synthesis of deoxy-ribose sugars for DNA synthesis, and regulating redox-sensitive gene expression. Auranofin is a gold compound that potently inhibits TrxR. This inhibition is one suspected mechanism of auranofin's therapeutic benefit in the treatment of rheumatoid arthritis. The use of other gold compounds to treat cancer or inflammatory disease may rely on their ability to inhibit TrxR. In the current study, we tested the hypothesis that a variety of gold compounds may inhibit TrxR. We exposed rat-TrxR1 to auranofin, gold sodium thiomalate, sodium aurothiosulfate, triphenyl phosphine gold chloride, or gold acetate, and measured TrxR activity ex vivo. We then compared TrxR1 inhibitory levels of gold compounds to those that inhibited mitochondrial activity of THP1 monocytes and OSC2 epithelial cells, estimated by succinate dehydrogenase activity. All gold compounds inhibited TrxR1 at concentrations ranging from 5 to 4000 nM (50% inhibitory concentration). The oxidation state of gold did not correlate with inhibitory potency, but ligand configuration was important. Au(I)-phosphine compounds (triphenyl phosphi...Continue Reading

References

Jan 1, 1992·Dental Materials : Official Publication of the Academy of Dental Materials·J C WatahaC T Hanks
Jan 1, 1995·Methods in Enzymology·A Holmgren, M Björnstedt
May 1, 1997·British Journal of Rheumatology·W F KeanW W Buchanan
Jun 29, 1999·Il Farmaco·F NovelliC Juliano
Sep 30, 2000·European Journal of Biochemistry·E S Arnér, A Holmgren
Sep 30, 2000·European Journal of Biochemistry·C H WilliamsR H Schirmer
Sep 30, 2000·European Journal of Biochemistry·K BeckerS Müller
Apr 5, 2002·Journal of Medicinal Chemistry·Giordana MarconGiovanni Minghetti
Jun 7, 2002·Critical Reviews in Oncology/hematology·Edward R T Tiekink
Sep 6, 2002·Biochemical Pharmacology·Dale A Dickinson, Henry Jay Forman
Sep 6, 2002·Biochemical Pharmacology·Giuseppe FilomeniMaria Rosa Ciriolo
Nov 5, 2003·Medicinal Research Reviews·Stephan GromerKatja Becker
Mar 3, 2004·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·R Eisler
Oct 2, 2004·Journal of Inorganic Biochemistry·Maria Pia RigobelloAlberto Bindoli
Jun 16, 2005·Cancer Letters·Phuongmai NguyenDavid Gius
Dec 27, 2005·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Yo OmataJohn C Wataha

❮ Previous
Next ❯

Citations

Aug 15, 2014·Biochimica Et Biophysica Acta·Zhichao ZhangJianru Xiao
Nov 13, 2008·Antioxidants & Redox Signaling·Jennifer D TibodeauKeith C Bible
Aug 17, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Melissa A FathDouglas R Spitz
Sep 23, 2009·Antioxidants & Redox Signaling·Markus SeleniusMikael Björnstedt
Jan 11, 2012·Antioxidants & Redox Signaling·Melissa M StaceyChristine C Winterbourn
May 28, 2009·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·Martin HaeublWolfgang Schoefberger
Jun 23, 2009·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·Angela CasiniLuigi Messori
Dec 30, 2015·Advanced Drug Delivery Reviews·Sohyoung HerChristine Allen
Dec 15, 2011·Journal of Inorganic Biochemistry·Fulvio SaccocciaAndrea Bellelli
Oct 21, 2009·Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP·Sara TedescoDavid Sheehan
Sep 22, 2009·Free Radical Biology & Medicine·Sofi E ErikssonElias S J Arnér
Feb 5, 2008·European Journal of Pharmacology·Maria Pia RigobelloAlberto Bindoli
Jan 8, 2008·Journal of Inorganic Biochemistry·Angela CasiniLuigi Messori
Oct 26, 2007·Dental Materials : Official Publication of the Academy of Dental Materials·John C WatahaJason M Hansen
Nov 4, 2008·Molecular Nutrition & Food Research·Kathryn F Tonissen, Giovanna Di Trapani
Jul 27, 2007·Basic & Clinical Pharmacology & Toxicology·Greicy M M ConteratoTatiana Emanuelli
Oct 19, 2011·Journal of Cellular and Molecular Medicine·Markus SeleniusAristi P Fernandes
Dec 19, 2013·Basic & Clinical Pharmacology & Toxicology·Greicy M M ConteratoTatiana Emanuelli
Jul 28, 2009·Medicinal Research Reviews·Stefania NobiliLuigi Messori
Feb 18, 2010·Chemistry : a European Journal·Raymond Wai-Yin SunChi-Ming Che
Aug 25, 2009·Journal of Biomedical Materials Research. Part a·Ryan R DavisJohn C Wataha
Oct 24, 2006·Seminars in Cancer Biology·Sabine Urig, Katja Becker
Jul 2, 2015·Toxicon : Official Journal of the International Society on Toxinology·Marco PirazziniCesare Montecucco
Jun 11, 2015·Antioxidants & Redox Signaling·Marcus CebulaElias S J Arnér
Feb 11, 2015·Journal of Inorganic Biochemistry·Telisha Traut-JohnstoneD Bradley G Williams
Aug 12, 2014·Biochemical Society Transactions·Helen R GriffithsChristopher R Dunston
Aug 1, 2015·Evidence-based Complementary and Alternative Medicine : ECAM·Cassia SacchetAngelo L Piato
Apr 20, 2016·Molecular Pharmaceutics·Marike W van GisbergenKatarina Johansson
Apr 29, 2015·Toxicon : Official Journal of the International Society on Toxinology·Leonie SchnellHolger Barth
Nov 12, 2010·Metallomics : Integrated Biometal Science·Sarah Elizabeth Jackson-Rosario, William Thomas Self
Jul 13, 2016·Cellular Microbiology·Domenico Azarnia TehranCesare Montecucco
Aug 29, 2016·European Journal of Cell Biology·Maneet BhatiaKathryn F Tonissen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.